BridgeBio Pharma, Inc. (BIT:1BBIO)

BridgeBio Pharma Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 9, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Cap	9,126	4,488	6,083	988	2,115	7,518
Market Cap Growth	120.95%	-26.22%	515.81%	-53.30%	-71.87%	101.55%
Enterprise Value	10,082	5,396	7,212	2,070	2,880	7,461
PE Ratio	-	-9.53	-10.22	-2.34	-4.28	-18.71
PS Ratio	45.45	23.50	759.77	14.78	35.25	1059.02
PB Ratio	-6.03	-3.55	-5.22	-0.91	-2.82	150.86
P/TBV Ratio	-5.01	-3.48	-4.85	-0.90	-2.77	144.90
P/FCF Ratio	-	-10.00	-13.36	-2.70	-4.81	-21.45
P/OCF Ratio	-	-10.01	-13.39	-2.74	-4.94	-21.86
EV/Sales Ratio	49.70	28.26	900.85	30.98	48.01	1050.94
EV/EBITDA Ratio	-	-10.68	-13.95	-4.76	-5.86	-18.33
EV/EBIT Ratio	-	-10.57	-13.80	-4.70	-5.80	-18.27
EV/FCF Ratio	-18.03	-12.02	-15.84	-5.67	-6.55	-21.29
Debt / Equity Ratio	-1.04	-1.18	-1.29	-1.38	-1.99	4.62
Debt / EBITDA Ratio	-2.85	-2.95	-2.90	-3.41	-3.02	-1.05
Debt / FCF Ratio	-2.83	-3.32	-3.29	-4.06	-3.38	-1.22
Asset Turnover	0.24	0.30	0.02	0.09	0.08	0.01
Quick Ratio	4.74	4.44	3.04	4.03	6.34	6.35
Current Ratio	5.19	4.67	3.32	4.52	6.58	6.72
Return on Equity (ROE)	48.52%	38.80%	50.52%	45.93%	154.18%	-174.31%
Return on Assets (ROA)	-65.66%	-81.08%	-103.88%	-62.62%	-67.19%	-71.07%
Return on Capital (ROIC)	-262.58%	-360.32%	-736.09%	-476.72%	-575.37%	-646.87%
Return on Capital Employed (ROCE)	-78.65%	-101.58%	-134.35%	-74.27%	-77.63%	-80.47%
Earnings Yield	-7.24%	-10.50%	-9.78%	-42.78%	-23.38%	-5.34%
FCF Yield	-6.13%	-10.00%	-7.48%	-36.97%	-20.80%	-4.66%
Buyback Yield / Dilution	-0.07%	-6.05%	-6.40%	-0.57%	10.96%	0.43%
Total Shareholder Return	-	-6.05%	-6.40%	-0.57%	10.96%	0.43%

Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.